Acute generalized exanthematous pustulosis induced by itraconazole.
作者信息
Park Y M, Kim J W, Kim C W
机构信息
Department of Dermatology, Catholic University Medical College, Seoul, Korea.
出版信息
J Am Acad Dermatol. 1997 May;36(5 Pt 1):794-6. doi: 10.1016/s0190-9622(97)80353-2.
PMID:9146550
Abstract
摘要
相似文献
1
Acute generalized exanthematous pustulosis induced by itraconazole.
J Am Acad Dermatol. 1997 May;36(5 Pt 1):794-6. doi: 10.1016/s0190-9622(97)80353-2.
2
Pustular psoriasis induced by terbinafine : differential diagnosis from acute generalized exanthematous pustulosis.
Eur J Dermatol. 2008 Nov-Dec;18(6):725-6. doi: 10.1684/ejd.2008.0535.
3
Rare case of itraconazole induced SDRIFE (symmetrical drug-related intertriginous and flexural exanthema).
J Dtsch Dermatol Ges. 2024 Jun;22(6):833-836. doi: 10.1111/ddg.15381. Epub 2024 Apr 3.
4
Acute generalized exanthematous pustulosis induced by terbinafine.
Arch Dermatol. 1996 Oct;132(10):1253-4. doi: 10.1001/archderm.132.10.1253.
5
Acute generalized exanthematous pustulosis following oral nystatin therapy: a report of three cases.
Br J Dermatol. 1997 Nov;137(5):808-11.
6
A case of eperisone hydrochloride-induced acute generalized exanthematous pustulosis.
J Dermatol. 2004 Sep;31(9):769-70. doi: 10.1111/j.1346-8138.2004.tb00595.x.
7
Ibuprofen-induced acute generalized exanthematous pustulosis.
Int J Dermatol. 2004 Mar;43(3):208-10. doi: 10.1111/j.1365-4632.2004.01860.x.
8
Terbinafine-induced acute generalized exanthematous pustulosis confirmed by a positive patch-test result.
J Am Acad Dermatol. 1997 Oct;37(4):653-5. doi: 10.1016/s0190-9622(97)70191-9.
9
Acute generalized exanthematous pustulosis.
Australas J Dermatol. 1995 Feb;36(1):25-7. doi: 10.1111/j.1440-0960.1995.tb00920.x.
10
Clindamycin-associated acute generalized exanthematous pustulosis.
Contact Dermatitis. 2003 Mar;48(3):169. doi: 10.1034/j.1600-0536.2003.00031.x.
引用本文的文献
1
Symmetric Drug-related Intertriginous and Flexural Exanthema due to Itraconazole: An Uncommon Side Effect of a Commonly Used Drug.
Indian Dermatol Online J. 2017 Nov-Dec;8(6):501-503. doi: 10.4103/idoj.IDOJ_179_17.
2
Safety and tolerability of oral antifungal agents in the treatment of fungal nail disease: a proven reality.
Ther Clin Risk Manag. 2005 Dec;1(4):299-306.
3
Skin manifestations of drug reactions.
Curr Allergy Asthma Rep. 2002 Jul;2(4):282-7. doi: 10.1007/s11882-002-0051-9.
Zotero 插件